Pricing Log in Create free account

Evommune Inc. (EVMN) vs Pyxis Oncology, Inc. (PYXS)

Evommune Inc. and Pyxis Oncology, Inc. are both Biotechnology companies. Evommune Inc. and Pyxis Oncology, Inc. are of similar size ($215.3M and $215.2M). Across the 10 metrics below, Evommune Inc. leads on 6 and Pyxis Oncology, Inc. on 4.

Valuation

Metric EVMN PYXS Biotechnology median
P/E n/m n/m 8.42
P/S n/m n/m 10.01
P/B 0.77 10.07 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales n/m n/m 9.41
Earnings yield (186.00%) (78.33%) (31.85%)
Free cash flow yield (34.84%) (58.96%) (24.58%)

Profitability

Metric EVMN PYXS Biotechnology median
Gross margin — 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (141.99%) (179.10%) (56.36%)
Return on assets (62.71%) (99.62%) (48.04%)
Return on invested capital (82.46%) 0.00% 0.00%

Growth

Metric EVMN PYXS Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 75.23% 3.03% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EVMN PYXS Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.68 1.34 4.72
Net debt to EBITDA 1.87 0.82 0.96

Dividend

Metric EVMN PYXS Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric EVMN PYXS Biotechnology median
Market cap 215.22m 215.25m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack